Rony Pain is dedicated to addressing the significant issue of cancer metastasis, responsible for approximately 90% of cancer-related deaths. His research focuses on PCLX-001, an investigational drug shown to inhibit the metabolism of aggressive breast cancer cells, potentially preventing their spread and offering a promising solution to the metastasis problem, ultimately benefiting numerous patients facing aggressive and lethal cancers.
*Due to technical difficulties, a small portion of the pitch is unavailable.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Breaking the Wall of Cancer Therapy
Rony Pain is a PhD student in the department of Cell Biology and the University of Alberta. He earned his BSc at the University of Alberta and then transitioned into his graduate studies. Rony is currently working in Dr Luc Berthiaume’s laboratory, where he investigates the effect of a new, investigational cancer drug, PCLX-001, on breast cancer metastasis and relapse. Rony has received prestigious awards, such as the Sir Frederick Banting and Dr. Charles Best Canada Graduate Scholarship. He enjoys attending conferences and seminars to learn more about how he can make a strong impact on society through his research.
Further Activities to have a look at